SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ethereum is a global, open-source platform for decentralized applications. In other words, the vision is to create a world computer that anyone can build applications in a decentralized manner; while all states and data are distributed and publicly accessible. Ethereum supports smart contracts in which developers can write code in order to program digital value. Examples of decentralized apps (dapps) that are built on Ethereum includes tokens, non-fungible tokens, decentralized finance apps, lending protocol, decentralized exchanges, and much more.  On Ethereum, all transactions and smart contract executions require a small fee to be paid. This fee is called Gas. In technical terms, Gas refers to the unit of measure on the amount of computational effort required to execute an operation or a smart contract. The more complex the execution operation is, the more gas is required to fulfill that operation. Gas fees are paid entirely in Ether (ETH), which is the native coin of the blockchain. The price of gas can fluctuate from time to time depending on the network demand.

Ethereum

Ethereum is trending as the community debates recent price action and potential market manipulation, with some expressing frustration over its inability to sustain gains. Discussions include speculation on upcoming catalysts and technical analysis, while others point to concerns over the influence of large investment firms. Overall, sentiment seems mixed with a focus on identifying the next key price levels.

GSI Technology, Inc. engages in the design, development and marketing of memory products primarily for the networking, and telecommunications markets. Its product includes Static Random Access Memory, or SRAM, which incorporated in networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations and network access equipment. It also offers services to the ongoing needs of the military, industrial, test and measurement equipment, automotive and medical markets for SRAMs .The company was founded by Lee-Lean Shu and Robert Yau in March 1995 and is headquartered in Sunnyvale, CA.

GSI Technology Inc

GSI Technology is trending due to a Cornell University study highlighting its APU's comparable performance to NVIDIA GPUs with significantly lower energy consumption, sparking community interest in potential buyouts and market disruption within the AI space. Community members are actively discussing the implications for the AI market and potential competition with major players, while some speculate on possible acquisitions. The stock's surge is also attracting attention from traders looking for the next big move in the AI and semiconductor sectors.

HIVE Digital Technologies Ltd. engages in building a bridge between the digital currency and blockchain sector and traditional capital markets. It operates data centers for computing and mining cryptocurrencies, including Bitcoin and other coins. The firm owns and operates green energy-powered data center facilities in Canada, Sweden, and Iceland. Its project includes Iceland Cryptocurrency Mining. HIVE Digital Technologies was founded on June 24, 1987 and is headquartered in San Antonio, TX.

HIVE Digital Technologies Ltd.

HIVE Digital Technologies Ltd

HIVE Digital Technologies is trending due to its strategic shift towards high-performance computing (HPC) and AI infrastructure, highlighted by a partnership with Bell Canada to build a sovereign AI ecosystem. The community is discussing analyst ratings boosts and expansion into renewable-powered data centers, viewing HIVE as more than just a Bitcoin miner. This transition diversifies HIVE's revenue streams and positions it to capitalize on the growing demand for AI and HPC solutions.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is trending as community members discuss the potential impact of upcoming catalysts, including a CMS rule update, real-world data releases, and potential TDAPA legislation; the company's recent earnings and revenue guidance are also sparking debate around future growth and valuation. Community members are focused on Rezzayo data and its efficacy against deadly fungus, as well as potential financial outcomes based on analyst estimates.

Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.

Verastem Inc

Verastem ($VSTM) is trending due to positive clinical data from a partner's lung cancer drug trial in China, demonstrating promising response rates. The community is actively discussing the implications of these results, comparing them to competitors and speculating on potential short squeezes. Despite optimism, concerns about cash position, past volatility, and management's history temper enthusiasm among some investors.

Duos Technologies Group, Inc. designs, develops, deploys, and operates intelligent technology solutions supporting rail, logistics, intermodal and government customers that streamlines operations, improves safety and reduces costs. It offers imaging, safety and security, software, and services. The firm also provides cutting edge solutions that automate the mechanical and security inspection of fast moving trains, trucks and automobiles through a broad range of proprietary hardware, software, information technology and artificial intelligence. The company was founded on May 31, 1994 and is headquartered in Jacksonville, FL.

Duos Technologies Group Inc

Duos Technologies ($DUOT) is trending due to growing excitement around its AI-driven solutions for data centers and gas turbine infrastructure. Community members are discussing the company's potential in hot market segments and its undervalued status, with some suggesting the company hasn't effectively communicated its full story. Positive catalysts, including rising earnings, recurring revenue, and Class I contracts, are also fueling interest.

Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. It focuses on developing BNC210, an oral drug designed for the acute treatment of social anxiety disorder (SAD) and the chronic treatment of post-traumatic stress disorder (PTSD) by selectively targeting the a7 nicotinic acetylcholine receptor. The company was founded on December 23, 2024 and is headquartered in Burlington, MA.

Neuphoria Therapeutics Inc.

NEUP is trending due to a failed phase 3 trial for its anxiety drug, though discussions highlight its partnership with Merck for an Alzheimer's drug and a cash runway extending to Q2 2027. Despite the trial setback, some traders believe the stock is oversold, presenting a short-term buying opportunity, while others are concerned about the company's cash position and pipeline.

What Is Tezos (XTZ)?   Tezos is a high-performing blockchain and open-source platform for assets and applications, with a strong focus on code security, on-chain governance, and decentralization. Tezos 2.0, the upcoming step in the evolution of Tezos, aims to improve scalability (via layer 2s), composability, and to implement support to mainstream programming languages (like Javascript, Typescript, Python, and many others).   Initially built with formal verification in mind, the Tezos protocol enables builders to avoid bugs when developing smart contracts, making it particularly suited to applications that require a high degree of security and certainty.   Tezos’ LPoS (Liquid Proof-of-Stake) consensus mechanism enables any stakeholder to take part, directly or by delegation, in the consensus process, and to be rewarded for securing the network. Rather uniquely, Tezos’ on-chain governance system also enables stakeholders to create and vote on protocol upgrade proposals. This pioneering system allows the protocol to self-amend and upgrade itself without leading to a split (or fork) in the blockchain, empowering the community without slowing down innovation.   First proposed in 2014 and launched in 2018, the Tezos Mainnet has a proven track record of running uninterrupted ever since, having earned a strong reputation for technical excellence and a supportive community.    Who Are the Founders of Tezos? Tezos was conceived by Arthur and Kathleen Breitman in a 2014 white paper under the pseudonym L.M. Goodman in a nod to Satoshi Nakamoto, referencing a journalist who had misidentified the creator of Bitcoin.   In a previous paper, the Breitmans had argued that Bitcoin's biggest shortcomings were the lack of a governance process that invited contributions from its community of users, cost and centralization issues raised by its proof-of-work system, the limited expressiveness of its programming language which didn’t allow for smart contracts, and security

Tezos

Tezos ($XTZ) is trending amidst discussions about potential market movements and the impact of macroeconomic factors like FED rate cuts. Community members are debating whether to hold or sell, with some expressing concerns about its potential while others anticipate a bullish altcoin season. The conversation includes speculation about potential price targets and frustration with the token's performance.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

CADL is trending as investors await key updates on its pipeline, particularly CAN-3110 data, while also weighing the implications of recent non-dilutive financing. Discussions center on potential partnerships, the company's financial positioning, and the long-term prospects for its cancer therapies. Bullish community members express confidence in upcoming catalysts and Candel's potential within the broader biotech sector.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

Grayscale Bitcoin Mini Trust ETF ($BTC) is trending as Bitcoin flirts with all-time highs, driving community excitement and discussions around potential breakouts. Traders are actively watching key resistance levels and analyzing potential breakouts, while also speculating about the impact of potential government shutdowns on crypto. Bullish sentiment is fueled by the possibility of new all-time highs and expectations of substantial gains.

statis crypto Watchlist

Bitcoin

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

UNDER ARMOUR ANNOUNCES SECOND QUARTER FISCAL 2026 EARNINGS CONFERENCE CALL DATE

UNDER ARMOUR ANNOUNCES SECOND QUARTER FISCAL 2026 EARNINGS CONFERENCE CALL DATE UNDER ARMOUR ANNOUNCES SECOND QUARTER FISCAL 2026 EARNINGS CONFERENCE CALL DATE PR Newswire BALTIMORE, Oct. 16, 2025...

Goldman cautious on mid cap athleisure, starts Crocs, Deckers at Sell

Investing.com -- Goldman Sachs began coverage of mid‑cap U.S. athleisure names with a cautious stance, arguing that stiffer competition and fickle consumer demand will separate winners from laggards in the crowded footwear and sportswear arena.

Wall Street analyst breaks down the impact of U.S. tariffs on the retail sector

Investing.com - Although the retail sector appears to be one of the hardest-hit by U.S. President Donald Trump's aggressive tariffs on China, some of these companies could be insulated from the levies following a multi-year push to diversify the countries they source products from, according to analysts at Telsey Group.

How Income-Focused Investors Should Use Lululemon’s Unusual Options Activity to Play Q4 2024 Earnings Report

Lululemon reports its all-important Q4 2024 earnings after today’s close. In Wednesday trading, it had three unusually active options. Here’s how income-focused investors can use its unusual options activity to go long on the lifestyle retailer.

Under Armour Stock Surges as Sales, Adjusted Profit Top Estimates

Mike Kemp / In Pictures via Getty ImagesKey TakeawaysShares of Under Armour rose 5% in premarket trading Thursday after the apparel maker's sales and adjusted profit topped estimates.The company...

UNDER ARMOUR REPORTS THIRD QUARTER 2025 RESULTS; RAISES FISCAL 2025 OUTLOOK

UNDER ARMOUR REPORTS THIRD QUARTER 2025 RESULTS; RAISES FISCAL 2025 OUTLOOK UNDER ARMOUR REPORTS THIRD QUARTER 2025 RESULTS; RAISES FISCAL 2025 OUTLOOK PR Newswire BALTIMORE, Feb. 6, 2025 BALTIMORE...

Shares of Under Armour ($UA) have been in the spotlight ahead of the apparel company’s third-quarter earnings, with retail sentiment staying upbeat.Wall Street analysts expect the company to post earnings per share of $0.03 on revenue of $1.34 billion, according to Stocktwits data. The company beat earnings in all four quarters in the past year for EPS, and delivered a revenue beat three out of four quarters.Under Armour competitors VF Corp and Columbia Sportswear reported earnings beat recently. VF Corp posted revenue growth of 1.9% year–over-year, while Columbia Sportswear revenues rose 3.5%.In December, Under Armour reiterated its full-year fiscal 2025 outlook."Today, we reviewed our plans to enhance and fortify the Under Armour brand, highlighting our seasoned leadership team's commitment to ensuring consistent execution with improved alignment, clarity, and confidence about our future direction…I am confident that our actions are gaining traction,” said CEO Kevin Plank “We are running a more agile and focused company, and our strategies are fostering renewed brand strength, which we believe will ultimately improve our ability to drive sustainable, profitable growth for our shareholders."Last month Barclays lowered the firm's price target on Under Armour to $11 from $12 with an ‘Equal Weight’ rating following the management outlining its near- and long-term strategic initiatives to return to growth and capture market share.Last quarter, the company posted $0.30 in EPS, beating estimates of $0.19.Sentiment on Stocktwits has stayed ‘bullish’ from a day ago. Message volumes have been in the ‘normal’ zone.<figure class="image"><img style="aspect-ratio:1294/302;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_02_06_at_7_20_27_AM_b85f427a20.png" alt="Screenshot 2025-02-06 at 7.20.27 AM.png" width="1294" height="302"><figcaption>UA sentiment meter and message volumes on Feb 5 as of 8:45 pm ET</figcaption></figure>Under Armour is a distributor of branded athletic performance apparel, footwear, and accessories.Under Armour stock is down 0.48% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Under Armour Stock In Focus Ahead Of Q3 Earnings: Retail’s Bullish

Wall Street analysts expect the company to post earnings per share of $0.03 on revenue of $1.34 billion

Equity

UNDER ARMOUR ANNOUNCES THIRD QUARTER FISCAL 2025 EARNINGS CONFERENCE CALL DATE

UNDER ARMOUR ANNOUNCES THIRD QUARTER FISCAL 2025 EARNINGS CONFERENCE CALL DATE UNDER ARMOUR ANNOUNCES THIRD QUARTER FISCAL 2025 EARNINGS CONFERENCE CALL DATE PR Newswire BALTIMORE, Jan. 23, 2025...

2 Growth Stocks to Buy in January Under $200

Wall Street rates both these growth stocks a “Strong Buy.”

Under Armour is an under-appreciated retail stock, says BMO's Simeon Siegel

Simeon Siegel, BMO Capital Markets analyst, joins 'Squawk on the Street' to discuss the potential risks for the retail sector...

Under Armour, Inc. engages in the development, marketing, and distribution of branded performance apparel, footwear, and accessories for men, women, and youth. It operates through the following geographical segments: North America, EMEA, Asia-Pacific, Latin America, and Other. The company was founded by Kevin A. Plank in 1996 and is headquartered in Baltimore, MD.

Under Armour Inc - Ordinary Shares - Class C

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Netflix Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

UA
Under Armour Inc Class C

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest UA News

UAUnder Armour Inc Class C